Anondita Medicare Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹89(61.38%)
Premium (ELP)
Following its successful public offering, Anondita Medicare Limited's made its market debut on Sep 01, 2025 and is now actively traded on the NSEplatform. The IPO mobilized 47,93,000 Shares in total capital, including 47,93,000 Shares in primary equity infusion.
The offering was structured with a price band of ₹137 to ₹145 and minimum investment lots of 1000 shares. Investor participation during the subscription window from Aug 22, 2025 to Aug 26, 2025 demonstrated market confidence in the company's prospects.
The allotment process concluded on Aug 28, 2025, allocating shares to successful bidders. The listing represents the culmination of the IPO process, transitioning the company to publicly traded status with enhanced transparency and governance standards.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Anondita Medicare Limited, founded in March 2024, is a condom manufacturer best known for its flagship brand “COBRA,” producing around 562 million flavored male condoms annually. Its manufacturing facility is located in Noida, Uttar Pradesh, and the company exports to Southeast Asia, Africa, and the Middle East. Partnering with global health organizations, NGOs, and governments, Anondita supports family planning and public health initiatives. With a strong distribution network, it ensures timely delivery through wholesalers, retailers, e-commerce platforms, and government health programs. As of July 31, 2025, the company employed 280 people.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Regional Market Leadership: strong brand presence and recognition in North India
- Innovative Product Portfolio: wide range including flavored and specialty condoms
- Strong Distribution Network: established supply chain across domestic and international markets
- Cash Flow Strain: past and possible future negative cash flows may impact growth and operations
- Revenue Concentration Risk: heavy dependence on top 10 customers increases vulnerability
- Government Contract Reliance: significant dependence on tenders exposes business to regulatory and compliance risks
- Mr. Anupam Ghosh
- Mrs. Sonia Ghosh
- Mr. Reshant Ghosh
Anondita Medicare Limited
Maashitla Securities Private Limited